Milan: downside move for Pharmanutra
(Teleborsa) - Negative trading results for the pharmaceutical company specialized in the development of nutraceutical supplements and medical devices as it declines -2.45%.The technical scenario for Pharmanutra in the last week shows the security lagging behind the FTSE Italia Mid Cap. As compared to the related index, the security has shown a lower performance.
The technical scenario for Pharmanutra shows a continuation of the downtrend to test support at 51.17 Euros, with a resistance area at 52.47. The bearish pattern suggests that new lows will probably be tested in the 50.63 area.
These analyses are to be considered solely for information purposes and are not in any way intended to constitute financial advice, a solicitation of funds from the public or the promotion of any form of investment.
(Teleborsa Research Department)
(Teleborsa) 04-19-2024 12:30 PM